Do impalpable stage T1c prostate cancers visible on ultrasound differ from those not visible?

Journal of Urology

Volumn 169, Issue 3, 2003, Pages 964-968

  Ohori, Makoto ^a   Kattan, Michael W ^a   Utsunomiya, Takuji ^a   Suyama, Kazuho ^a   Scardino, Peter T ^a   Wheeler, Thomas M ^a  

^a NONE

Author keywords

Neoplasm staging; Prostate; Prostatic neoplasms; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PALPATION; PRIORITY JOURNAL; PROSTATE CANCER; ULTRASOUND;

EID: 0037362846     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ju.0000049963.28489.ab     Document Type: Article

References (19)

1. Shinohara, K., Wheeler, T. M. and Scardino, P. T.: The appearance of prostate cancer on transrectal ultrasonography: correlation of imaging and pathological examinations. J Urol, 142: 76, 1989
2. Greene, D. R., Shabsigh, R. and Scardino, P. T.: Urologic ultrasonography. In: Campbell's Urology, 6th ed. Edited by P. C. Walsh, A. B. Retik, T. A. Stamey and E. D. Vaughan, Jr. Philadelphia: W. B. Saunders Co., vol. 1, chapt. 9, pp. 342-393, 1992
3. Ohori, M., Egawa, S., Shinohara, K., Wheeler, T. M. and Scardino, P. T.: Detection of microscopic extracapsular extension prior to radical prostatectomy for clinically localized prostate cancer. Br J Urol, 74: 72, 1994
4. Ohori, M., Wheeler, T. M., Greene, D. R. and Scardino, P. T.: Comparison of the pathologic features and DNA ploidy value of prostate cancers detectable by sonography and by palpation. Prostate, 23: 271, 1993
5. Beahrs, O. H., Henson, D. E., Hutter, R. V. and Myers, M. H.: American Joint Committee on Cancer Staging Manual, 4th ed. Philadelphia: Lippincott-Raven, pp. 181-186, 1992
6. Ohori, M., Wheeler, T. M. and Scardino, P. T.: The new American Joint Committee on Cancer and International Union against Cancer TNM classification of prostate cancer: clinicopathologic correlations. Cancer, 74: 104, 1994
7. Fleming, I. D., Cooper, J. S., Murphy, G. P., Sullivan, B. O. Sobin, L. H., Yarbo, J. W. et al: American Joint Committee on Cancer Staging Manual, 5th ed. Philadelphia: Lippincott-Raven, pp. 219-222, 1997
8. Ferguson, J. K. and Oesterling, J. E.: Patient evaluation if prostate-specific antigen becomes elevated following radical prostatectomy or radiation therapy. Urol Clin North Am, 21: 677, 1994
9. Werner-Wasik, M., Whittington, R., Malkowicz, S. B., Corn, B. W., Arger, P., Reisinger, S. et al: Prostate imaging may not be necessary in nonpalpable carcinoma of the prostate. Urology, 50: 385, 1997
10. Tiguert, R., Gheiler, E. L., Grignon, D. J., Littrup, P. J., Sakr, W. and Pontes, J. E.: Patients with abnormal ultrasound of the prostate but normal digital rectal examination should be classified as having clinical stage T2 tumors. J Urol, 163: 1486, 2000
11. Ohori, M., Shinohara, K., Wheeler, T. M., Aihara, M., Wessels, E. C., Carter, S. S. et al: Ultrasonic detection of non-palpable seminal vesicle invasion: a clinicopathological study. Br J Urol, 72: 799, 1993
12. Wheeler, T. M. and Lebovitz, R. M.: Fresh tissue harvest for research from prostatectomy specimens. Prostate, 25: 274, 1994
13. Ohori, M., Goad, J. R., Wheeler, T. M., Eastham, J. A., Thompson, T. C. and Scardino, P. T.: Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol, 152: 1843, 1994
14. Greene, D. R., Egawa, S., Neerhut, G., Flanagan, W., Wheeler, T. M. and Scardino, P. T.: The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer. J Urol, 145: 324, 1991
15. Ferguson, J. K., Bostwick, D. G., Suman, V., Zincke, H. and Oesterling, J. E.: Prostate-specific antigen detected prostate cancer: pathological characteristics of ultrasound visible versus ultrasound invisible tumors. Eur Urol, 27: 8, 1995
16. Cookson, M. S., Fleshner, N. E., Soloway, S. M. and Fair, W. R.: Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy. Urology, 49: 887, 1997
17. Ramos, C. G., Carvalhal, G. F., Smith, D. S., Mager, D. E. and Catalona, W. J.: Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer. J Urol, 161: 1525, 1999
18. Ghavamian, R., Blute, M. L., Bergstralh, E. J., Slezak, J. and Zincke, H.: Comparison of clinically nonpalpable prostatespecific antigen-detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology, 54: 105, 1999
19. Elgamal, A.-A. A., Van Poppel, H. P., Van de Voorde, W. M., Van Dorpe, J. A., Oyen, R. H. and Baert, L. V.: Impalpable invisible stage T1c prostate cancer: characteristics and clinical relevance in 100 radical prostatectomy specimens - a different view. J Urol, 157: 244, 1997